Bivalirudin

FDA Approved: * July 14, 2015
Pharm Company: * HOSPIRA INC
Category: Blood Thinner (Anticoagulant)

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Bivalirudin Overview

Bivalirudin (Angiomax or Angiox, manufactured by The Medicines Company) is a direct thrombin inhibitor (DTI).[1] Chemically, it is a synthetic congener of the naturally occurring drug hirudin (found in the saliva of the medicinal leech Hirudo medicinalis). Bivalirudin is a DTI that overcomes many limitations seen with indirect thrombin inhibitors, such as heparin. Bivalirudin is a short, synthetic peptide. It is a potent and highly specific inhibitor of thrombin.[1&...

Read more Bivalirudin Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Bivalirudin

Recent Bivalirudin Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Bivalirudin
  • Injection: 250mg, 250mg/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Bivalirudin: (13 results)

Sorted by National Drug Code
  • 0338-9572 Bivalirudin In 0.9% Sodium Chloride In 0.9% Sodium Chloride 250 mg/50ml Intravenous Injection by Baxter Healthcare Corporation
  • 0338-9576 Bivalirudin In 0.9% Sodium Chloride In 0.9% Sodium Chloride 500 mg/100ml Intravenous Injection by Baxter Healthcare Corporation
  • 0409-8300 Bivalirudin 250 mg Intravenous Injection, Powder, Lyophilized, for Solution by Hospira, Inc.
  • 0781-3158 Bivalirudin 250 mg Intravenous Injection, Powder, Lyophilized, for Solution by Sandoz
  • 0781-9158 Bivalirudin 250 mg Intravenous Injection, Powder, Lyophilized, for Solution by Sandoz
  • 16729-275 Bivalirudin 250 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Accord Healthcare, Inc.
  • 25021-405 Bivalirudin 250 mg Intravenous Injection, Powder, Lyophilized, for Solution by Sagent Pharmaceuticals
  • 55111-652 Bivalirudin 250 mg Intracavernous Injection by Dr. Reddy's Laboratories Limited
  • 55150-210 Bivalirudin 250 mg Intravenous Injection, Powder, Lyophilized, for Solution by Auromedics Pharma LLC
  • 60505-6101 Bivalirudin 250 mg Intravenous Injection, Powder, Lyophilized, for Solution by Apotex Corp
  • 63323-562 Bivalirudin 250 mg Intravenous Injection, Powder, Lyophilized, for Solution by Fresenius Kabi USA, LLC
  • 67457-256 Bivalirudin 250 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Mylan Institutional LLC
  • 69097-601 Bivalirudin 250 mg Intravenous Injection by Cipla USA Inc.

Other drugs which contain Bivalirudin or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 18 April 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA